986 related articles for article (PubMed ID: 14980574)
1. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
[TBL] [Abstract][Full Text] [Related]
3. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
8. New and reliable MRI diagnosis for progressive supranuclear palsy.
Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
[TBL] [Abstract][Full Text] [Related]
9. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
10. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
11. [Neuroimaging features in progressive supranuclear palsy and corticobasal degeneration].
Mori E
Rinsho Shinkeigaku; 2002 Nov; 42(11):1158-61. PubMed ID: 12784693
[TBL] [Abstract][Full Text] [Related]
12. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
[TBL] [Abstract][Full Text] [Related]
13. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
[TBL] [Abstract][Full Text] [Related]
14. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
Cosottini M; Ceravolo R; Faggioni L; Lazzarotti G; Michelassi MC; Bonuccelli U; Murri L; Bartolozzi C
Acta Neurol Scand; 2007 Jul; 116(1):37-42. PubMed ID: 17587253
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters.
Minnerop M; Specht K; Ruhlmann J; Schimke N; Abele M; Weyer A; Wüllner U; Klockgether T
Neuroimage; 2007 Jul; 36(4):1086-95. PubMed ID: 17512219
[TBL] [Abstract][Full Text] [Related]
16. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
[TBL] [Abstract][Full Text] [Related]
17. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
[TBL] [Abstract][Full Text] [Related]
18. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
20. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]